SBIR Phase I: Automated Blood Flow Analysis Using Adaptive Three-Dimensional Ultrasound

SBIR 第一阶段：使用自适应三维超声进行自动血流分析

• 批准号: 1520315
• 负责人: David Narrow
• 金额: $ 14.99万
• 依托单位: Sonavex, Inc.
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-07-01 至 2016-06-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1520315&HistoricalAwards=false
• 关键词: SBIR; Phase; Automated; Blood; Flow

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project includes the reduction in severe patient morbidity and elimination of hundreds of millions of dollars of expenditures by the U.S. healthcare system each year on revision surgeries and unnecessary procedures associated with late detection of post-surgical blood clots. Surgeons have the ability to prevent these catastrophic events, but only the onset of the clot can be detected in a timely manner. Currently, of the patients who form clots after the targeted surgeries, half will suffer from a surgical failure due to the shortcomings of current modalities. This technology gives clinicians the ability to non-invasively track changes in blood flow within critical vessels to enable intervention prior to any compromise in health and prevent a majority of these catastrophic incidents. Beyond significant decreases in patient suffering and morbidity, such interventions will have an enormous positive economic impact on the health care system. This technology can also substantially improve clinical understanding of the clotting process and possibly enable non-invasive therapeutic treatments for these patients who otherwise would receive surgery.The proposed project offers significant intellectual and scientific merit associated with new methods of ultrasound flow analysis. The objective of this work is to develop a system that is able to collect a 3D volume of ultrasound data and automatically extract the blood flow data in the region of interest by detecting an implantable component. This novel approach to measuring vascular flow will be the first to enable detection of localized post-operative clot formation rather than detecting clot-related issues via delayed and indirect methods that leave patients at risk for surgical failures. This technique can allow for intervention earlier than all other available methods, thus improving patient outcomes and reducing hospital costs. Furthermore, this method enables automatic detection of critical changes in blood flow, eliminating the risk of human error. Lastly, dissemination of the technology developed in this proposal represents an important milestone towards the creation of simpler, more automated ultrasound systems that can place this non-invasive, non-ionizing modality in the hands of non-expert clinicians for use in a broader spectrum of medical applications.

这项小型企业创新研究（SBIR）第一阶段项目的更广泛影响/商业潜力包括降低严重患者的发病率，并消除美国医疗保健系统每年在翻修手术和与术后血栓晚期检测相关的不必要程序上的数亿美元支出。外科医生有能力预防这些灾难性事件，但只有血栓的发作才能及时发现。目前，在目标手术后形成血栓的患者中，一半将由于当前模式的缺点而遭受手术失败。这项技术使临床医生能够无创地跟踪关键血管内的血流变化，以便在健康受到任何损害之前进行干预，并防止大多数此类灾难性事件。除了显著降低患者的痛苦和发病率外，这种干预措施还将对卫生保健系统产生巨大的积极经济影响。这项技术还可以大大提高凝血过程的临床理解，并可能使非侵入性治疗这些患者谁，否则将接受surgical.The拟议的项目提供了显着的智力和科学价值与新方法的超声波流量分析。这项工作的目的是开发一种系统，能够收集三维体积的超声数据，并自动提取的血流数据在感兴趣的区域通过检测可植入的组件。这种测量血管流量的新方法将是第一种能够检测局部术后凝块形成的方法，而不是通过延迟和间接的方法检测凝块相关问题，这些方法会使患者面临手术失败的风险。这种技术可以比所有其他可用的方法更早地进行干预，从而改善患者的预后并降低医院成本。此外，该方法能够自动检测血流中的关键变化，消除人为错误的风险。最后，本提案中开发的技术的传播是创建更简单、更自动化的超声系统的一个重要里程碑，该系统可以将这种非侵入性、非电离模式交给非专家临床医生，用于更广泛的医疗应用。